Cargando…
Norepinephrine May Oppose Other Neuromodulators to Impact Alzheimer’s Disease
While much of biomedical research since the middle of the twentieth century has focused on molecular pathways inside the cell, there is increasing evidence that extracellular signaling pathways are also critically important in health and disease. The neuromodulators norepinephrine (NE), serotonin (5...
Autor principal: | Fitzgerald, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304567/ https://www.ncbi.nlm.nih.gov/pubmed/34298984 http://dx.doi.org/10.3390/ijms22147364 |
Ejemplares similares
-
Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo
por: Fitzgerald, Paul J.
Publicado: (2021) -
Is There a Novel Biosynthetic Pathway in Mice That Converts Alcohol to Dopamine, Norepinephrine and Epinephrine?
por: Fitzgerald, Paul J.
Publicado: (2022) -
Therapeutic Neuromodulation toward a Critical State May Serve as a General Treatment Strategy
por: Arvin, Simon, et al.
Publicado: (2022) -
A Hypothesis and Evidence That Mercury May be an Etiological Factor in Alzheimer’s Disease
por: Siblerud, Robert, et al.
Publicado: (2019) -
Porphyromonas Gingivalis May Seek the Alzheimer’s Disease Brain to Acquire Iron from Its Surplus
por: Olsen, Ingar
Publicado: (2021)